Exclusive: India's PharmEasy plans $200 million fund raising at lower valuation - Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QWOW55PLUZNKJFPOSOBOUILSXI.jpg)
7/19/2022 12:00:00 AM3 years 7 months ago
Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year's $5.1 billion, two people with direct knowledge of deal talks told Reuters.
MUMBAI, July 19 (Reuters) - Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year'… [+3746 chars]
full article...